58152-03-7CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](N)C[C@H]2NC(=O)[C@@H](O)CN)OC[C@]1(C)OUDIIBEDMEYAVNG-ZKFPOVNWSA-NIsepamicin is a broad-spectrum aminoglycoside antibiotic structurally related to gentamicin and amikacin. Isepamicin has activity similar to amikacin but with better activity against bacterial strains with resistance to other aminoglycosides, such as strains producing 6'-N-aminoglycoside acetyltransferase. Isepamicin is not metabolized and is excreted via the kidneys. This agent exerts a long postantibiotic effect allowing for once daily dosing.
58152-03-7DTXSID1048380CHEMBL272080Drug-Induced Liver Injury Severity and Toxicity (DILIst)
Isepamicin
DILI Positive
DOI:10.1016/j.drudis.2019.09.022
J - Antiinfectives for systemic use
QJ - Antiinfectives for systemic use
개요Isepamicin is a aminoglycoside antibiotic indicated for use in the treatment of urinary and respiratory tract infections. Although it is less potent than most other aminoglycosides, it is also less nephrotoxic. The broad-spectrum activity of isepamicin generally parallels that of amikacin in vitro.
용도Antibacterial (aminoglyco side).
현재 필터 조건에 해당하는 반응 기록이 없습니다.
불러오는 중…